Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32852 | 101 | 26.8 | 27% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2487 | 3478 | ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MUCOPOLYSACCHARIDE POLYSULFATE | Author keyword | 6 | 80% | 4% | 4 |
| 2 | CAS 530 78 9 | Author keyword | 1 | 50% | 1% | 1 |
| 3 | PERFUSED PIG EAR | Author keyword | 1 | 50% | 1% | 1 |
| 4 | POLICY INFORMAT | Address | 1 | 13% | 4% | 4 |
| 5 | T PA RELEASE | Author keyword | 0 | 20% | 1% | 1 |
| 6 | SYNTHETIC PROTEASE INHIBITOR | Author keyword | 0 | 14% | 1% | 1 |
| 7 | FLUFENAMIC ACID SKIN PENETRATION | Author keyword | 0 | 100% | 1% | 1 |
| 8 | HIRUDOID R | Author keyword | 0 | 100% | 1% | 1 |
| 9 | REPAIR OF DOUBLE STRANDED DNA BREAKS | Author keyword | 0 | 100% | 1% | 1 |
| 10 | TOPICAL TREATMENTS INFLAMMATION | Author keyword | 0 | 100% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MUCOPOLYSACCHARIDE POLYSULFATE | 0 | 33% | 1% | 1 |
| 2 | POLYL GLUTAMIC ACID RODS | 0 | 17% | 1% | 1 |
| 3 | ARTEPARON | 0 | 11% | 1% | 1 |
| 4 | ACID POLYPEPTIDES | 0 | 100% | 1% | 1 |
| 5 | HEPARIN ANALOG | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Topical mucopolysaccharide polysulfate (MPS) in the treatment of thrombophlebitis - A critical review | 2001 | 3 | 18 | 56% |
| TOPICAL CORTICOSTEROID-THERAPY - CONTINUOUS VERSUS DISCONTINUOUS APPLICATION | 1983 | 3 | 1 | 100% |
| MAST-CELLS AS AN EXPRESSION OF THEIR MAJOR COMPONENT, ANIONIC POLY-ELECTROLYTES | 1982 | 3 | 1 | 100% |
| UPDATE ON THE RELATIONSHIP OF HEPARIN TO ATHEROSCLEROSIS AND ITS THROMBOTIC COMPLICATIONS | 1988 | 12 | 197 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | POLICY INFORMAT | 1 | 13% | 4.0% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000169430 | BENZOCAINE HYDROCHLORIDE//STATE BIOMOL ELECT// |
| 2 | 0.0000159067 | AMIDOLYSIS//ELASTASE ALPHA1 PROTEINASE INHIBITOR//CLOT LYSIS ASSAY |
| 3 | 0.0000112399 | DICLOFENAC EPOLAMINE//DICLOFENAC SALTS//TOPICAL DICLOFENAC |
| 4 | 0.0000106287 | CELLULAR INHIBITION//INFECT DIS INVEST SCI//PENTOSAN POLYSULPHATE SODIUM |
| 5 | 0.0000100010 | ALPHA 1 ANTICHYMOTRYPSIN DEFICIENCY//PULMONARY ADENOCARCINOMA CELL LINE//SERPINE |
| 6 | 0.0000094746 | DING PROTEIN//DING PROTEINS//HUMAN PHOSPHATE BINDING PROTEIN |
| 7 | 0.0000094580 | NAFAMOSTAT MESILATE//PHARM PHARMACEUT HIGASHINADA KU//MED HOSP PHARM CHUO KU |
| 8 | 0.0000089668 | SULODEXIDE//INHALED HEPARIN//POLYANIONIC CHARGE |
| 9 | 0.0000081899 | DIPYRONE//METAMIZOL//PIFIR MODEL |
| 10 | 0.0000079480 | X RAY SCATTERING IN LIQUIDS//DICHLOROALKANES//DIFFERENTIAL RADIAL DISTRIBUTION FUNCTIONS |